<DOC>
	<DOCNO>NCT00352898</DOCNO>
	<brief_summary>Since measles-mumps-rubella ( MMR ) varicella vaccination establish routine childhood practice often co-administered second year life , combine measles-mumps-rubella-varicella ( MeMuRu-OKA ) vaccine fully justify . Such combined vaccine develop extensively study susceptible child . In country varicella mass-vaccination already implement , transition period necessary child start separate first-dose vaccination MMR varicella receive single shot combine vaccine second dose . To account situation , study evaluate effect combine measles-mumps-rubella-varicella vaccine give place separate MMR varicella vaccine second dose .</brief_summary>
	<brief_title>Immunogenicity , Safety Measles-mumps-rubella-varicella Vaccine ( MeMuRu-OKA ) Compared Priorix™ Given With Varilrix™</brief_title>
	<detailed_description />
	<mesh_term>Measles</mesh_term>
	<mesh_term>Rubella</mesh_term>
	<mesh_term>Mumps</mesh_term>
	<mesh_term>Chickenpox</mesh_term>
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Children must healthy participate immunosuppressive ( include HIV ) condition , allergic disease , neurological disorder , know anaphylactic reaction MMR vaccine , fever ( axillary temperature ³ 37.5°C time vaccination ) exclude factor . Children must receive one dose ( ) MMR varicella vaccine least 6 week enter study . They must receive receive nonregistered drug vaccine within 30 day prior study start , immunosuppressant 14 day . Immunoglobulins blood product prohibit 6 month study , well vaccine foreseen protocol , 30 day 56 day vaccination . They must measles , mumps , rubella varicella , expose disease within 30 day prior study start . Newborn infant ( &lt; 5 week age ) , pregnant woman without previous exposure chickenpox , immunodeficient person live household vaccinate child .</criteria>
	<gender>All</gender>
	<minimum_age>15 Months</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>